日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabine

阐明顺铂与吉西他滨磷酰胺化修饰物NUC-1031联合用药的作用机制

期刊:Translational Oncology
影响因子:4.5
doi:10.1016/j.tranon.2024.102114
Dillum Patel ，Alison L Dickson ，Greice M Zickuhr ，In Hwa Um ，Oliver J Read ，Clarissa M Czekster ，Peter Mullen ，David J Harrison ，Jennifer Bré
发表日期：2024
文献求助 收藏

DESI-MSI-guided exploration of metabolic-phenotypic relationships reveals a correlation between PI 38:3 and proliferating cells in clear cell renal cell carcinoma via single-section co-registration of multimodal imaging

DESI-MSI 引导的代谢表型关系探索通过多模态成像的单切片联合配准揭示了 PI 38:3 与透明细胞肾细胞癌中增殖细胞之间的相关性

期刊:Analytical and Bioanalytical Chemistry
影响因子:3.8
doi:10.1007/s00216-024-05339-0
Greice M Zickuhr, In Hwa Um, Alexander Laird, David J Harrison, Alison L Dickson
代谢
肾癌
肿瘤细胞
发表日期：2024
文献求助 收藏

The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent

新型抗癌氟嘧啶 NUC-3373 是胸苷酸合酶的强效抑制剂，也是一种有效的 DNA 损伤剂

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.7
doi:10.1007/s00280-023-04528-5
Jennifer Bré, Alison L Dickson, Oliver J Read, Ying Zhang, Fiona G McKissock, Peter Mullen, Peijun Tang, Greice M Zickuhr, Clarissa M Czekster, David J Harrison
肿瘤
WB
发表日期：2023
文献求助 收藏